Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: A systematic review

References

• Al-Chalabi A, Hardiman O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nature Reviews Neurology. 2013;9:617–28.
   PubMed Web of Science ®Google Scholar
• Averill AJ, Kasarskis EJ, Segerstrom SC. Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:243–54.
   PubMed Web of Science ®Google Scholar
• Kurt A, Nijboer F, Matuz T, Kuebler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs. 2007;21: 279–91.
   PubMed Web of Science ®Google Scholar
• Taylor L, Wicks P, Leigh PN, Goldstein LH. Prevalence of depression in amyotrophic lateral sclerosis and other motor disorders. European Journal of Neurology. 2010;17:1047–53.
   PubMed Web of Science ®Google Scholar
• Ferentinos P, Paparrigopoulos T, Rentzos M, Zouvelou V, Alexakis T, Evdokimidis I. Prevalence of major depression in ALS: comparison of a semi-structured interview and four self-report measures. Amyotroph Lateral Scler. 2011;12: 297–302.
   PubMed Web of Science ®Google Scholar
• Pagnini F, Manzoni GM, Tagliaferri A, Gibbons CJ. Depression and disease progression in amyotrophic lateral sclerosis: a comprehensive meta-regression analysis. Journal of Health Psychology. 2014; 1–22. epub 24 April. doi:10.1177/1359105314530453.
   Google Scholar
• Fang F, Valdimarsdottir U, Furst CJ, Hultman C, Fall K, Sparen P, et al. Suicide among patients with amyotrophic lateral sclerosis. Brain. 2008;131:2729–33.
   PubMed Web of Science ®Google Scholar
• Palmieri A, Soraru G, Albertini E, Semenza C, Vottero-Ris F, D’Ascenzo C, et al. Psychopathological features and suicidal ideation in amyotrophic lateral sclerosis patients. Neurological Sciences. 2010;31:735–40.
   PubMed Web of Science ®Google Scholar
• Stutzki R, Weber M, Reiter-Theil S, Simmen U, Borasio GD, Jox RJ. Attitudes towards hastened death in ALS: a prospective study of patients and family caregivers. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:68–76.
   PubMed Web of Science ®Google Scholar
• Maessen M, Veldink JH, Onwuteaka-Philipsen BD, Hendricks HT, Schelhaas HJ, Grupstra HF, et al. Euthanasia and physician-assisted suicide in amyotrophic lateral sclerosis: a prospective study. J Neurol. 2014;261:1894–901.
   PubMed Web of Science ®Google Scholar
• Clarke DM, McLeod JE, Smith GC, Trauer T, Kissane DW. A comparison of psychosocial and physical functioning in patients with motor neuron disease and metastatic cancer. J Palliat Care. 2005;21:173–9.
   PubMed Web of Science ®Google Scholar
• Stutzki R, Schneider U, Reiter-Theil S, Weber M. Attitudes Toward Assisted Suicide and Life-Prolonging Measures in Swiss ALS Patients and Their Caregivers. Front Psychol. 2012;3:443.
   PubMed Web of Science ®Google Scholar
• Albert SM, Rabkin JG, Del Bene ML, Tider T, O’Sullivan I, Rowland LP, et al. Wish to die in end-stage ALS. Neurology. 2005;65:68–74.
   PubMed Web of Science ®Google Scholar
• McDonald ER, Wiedenfeld SA, Hillel A, Carpenter CL, Walter RA. Survival in amyotrophic lateral sclerosis: the role of psychological factors. Archives of Neurology. 1994;51: 17–23.
   PubMed Web of Science ®Google Scholar
• Johnston M, Earll L, Giles M, McClenahan R, Stevens D, Morrison V. Mood as a predictor of disability and survival in patients newly diagnosed with ALS/MND. British Journal of Health Psychology. 1999;4:127–36.
   Web of Science ®Google Scholar
• Pizzimenti A, Aragona M, Onesti E, Inghilleri M. Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Functional Neurology. 2013;28:115–9.
   PubMedGoogle Scholar
• National Institute for Health and Care Excellence. NICE Clinical Guideline 91: Depression in adults with a chronic physical health problem: treatment and management. 2009.
   Google Scholar
• National Institute for Health and Care Excellence. NICE Clinical Guideline 123: Common mental health disorders: identification and pathways to care. 2011.
   Google Scholar
• Jaiswal R, Alici Y, Breitbart W. A comprehensive review of palliative care in patients with cancer. Int Rev Psychiatry. 2014;26:87–101.
   PubMed Web of Science ®Google Scholar
• Rayner L, Price A, Hotopf M, Higginson IJ. The development of evidence-based European guidelines on the management of depression in palliative cancer care. Eur J Cancer. 2011;47:702–12.
   PubMed Web of Science ®Google Scholar
• Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, van Damme P, et al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS): revised report of an EFNS task force. Eur J Neurol. 2012;19: 360–75.
   PubMed Web of Science ®Google Scholar
• Pagnini F, Simmons Z, Corbo M, Molinari E. Amyotrophic lateral sclerosis: time for research on psychological intervention? Amyotroph Lateral Scler. 2012;13:416–7.
   PubMed Web of Science ®Google Scholar
• Cochrane Collaboration (online). Available at: http://www.cochrane.org/.
   Google Scholar
• Averill AJ, Kasarskis EJ, Segerstrom SC. Expressive disclosure to improve well-being in patients with amyotrophic lateral sclerosis: a randomized, controlled trial. Psychology and Health. 2013;28:701–13.
   PubMed Web of Science ®Google Scholar
• Bentley B, Aoun SM, O’Connor M, Breen LJ, Chochinov HM. Is dignity therapy feasible to enhance the end-of-life experience for people with motor neuron disease and their family carers? Study protocol. BMC Palliative Care. 2012;11:18.
   PubMed Web of Science ®Google Scholar
• Bentley B, O’Connor M, Kane R, Breen LJ. Feasibility, acceptability, and potential effectiveness of dignity therapy for people with motor neuron disease. PLoS One. 2014;9: e96888.
   PubMed Web of Science ®Google Scholar
• Aoun SM, Chochinov HM, Kristjanson LJ. Dignity Therapy for People with Motor Neurone Disease and their Family Caregivers: A Feasibility Study. J Palliat Med. 2014; epub 14 Oct.
   Google Scholar
• Díaz JL, Sancho J, Barreto P, Bañuls P, Renovell M, Servera E. Effect of a short-term psychological intervention on the anxiety and depression of amyotrophic lateral sclerosis patients. J Health Psychol. 2014; epub 4 Nov.
   Google Scholar
• Palmieri A, Kleinbub JR, Calvo V, Sorarù G, Grasso I, Messina I. Efficacy of hypnosis-based treatment in amyotrophic lateral sclerosis: a pilot study. Front Psychol. 2012;3:465.
   PubMed Web of Science ®Google Scholar
• van Groenestijn AC, van de Port IGL, Schroder CD, Post MWM, Grupstra HF, Kruitwagen ET, et al. Effects of aerobic exercise therapy and cognitive behavioural therapy on functioning and quality of life in amyotrophic lateral sclerosis: protocol of the FACTS-2-ALS trial. BMC Neurology. 2011;11:70. http://www.biomedcentral.com/1471-2377/11/70.
   Google Scholar
• Narasimhan M. An Open-label, Eight-Week, Flexible Dose Trial of Escitalopram (Lexapro®) in Comorbid Major Depression With Amyotrophic Lateral Sclerosis and Multiple Sclerosis (NCT00965497). 2009. Available from: http://clinicaltrials.gov/show/NCT00965497.
   Google Scholar
• Rabkin JG. Coping Effectiveness Training for ALS (NCT01583205). 2012. Available from: http://clinicaltrials.gov/show/NCT01583205.
   Google Scholar
• Pagnini F, Di Credico C, Gatto R, Fabiani V, Rossi G, Lunetta C, et al. Meditation Training for People with Amyotrophic Lateral Sclerosis and Their Caregivers. Journal of Alternative and Complementary Medicine. 2014;20:272–5.
   PubMed Web of Science ®Google Scholar
• O’Leary OF, Dinan TG, Cryan JF. Faster, better, stronger: towards new antidepressant therapeutic strategies. Eur J Pharmacol. 2015;753:32–50.
   Google Scholar
• Gourley SL, Espitia JW, Sanacora G, Taylor JR. Anti-depressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice. Psychopharmacology (Berl). 2012;219:805–14.
   PubMed Web of Science ®Google Scholar
• Gould RL, Coulson MC, Howard RJ. Cognitive behavioural therapy for depression in older people: a meta-analysis and meta-regression of randomized controlled trials. J Am Geriatr Soc. 2012;60:1817–30.
   PubMed Web of Science ®Google Scholar
• Akechi T, Okuyama T, Onishi J, Morita T, Furukawa TA. Psychotherapy for depression among incurable cancer patients. Cochrane Database Syst Rev. 2008:CD005537.
   Web of Science ®Google Scholar
• Radunović A, Mitsumoto H, Leigh PN. Clinical care of patients with amyotrophic lateral sclerosis. The Lancet Neurology. 2007;6:913–25.
   PubMed Web of Science ®Google Scholar
• Graham CD, Simmons Z, Stuart SR, Rose MR. Issues & Opinions: the potential of psychological interventions to improve quality of life and mood in muscle disorders. Muscle Nerve. 2014. (Epub ahead of print).
   Web of Science ®Google Scholar
• Serfaty M, Csipke E, Haworth D, Murad S, King M. A talking control for use in evaluating the effectiveness of cognitive behavioural therapy. Behav Res Ther. 2011;49:433–40.
   PubMed Web of Science ®Google Scholar
• Williams JM, Crane C, Barnhofer T, Brennan K, Duggan DS, Fennell MJ, et al. Mindfulness based cognitive therapy for preventing relapse in recurrent depression: a randomized dismantling trial. J Consult Clin Psychol. 2014;82: 275–86.
   PubMed Web of Science ®Google Scholar
• Jenkins TM, Hollinger H, McDermott CJ. The evidence for symptomatic treatments in amyotrophic lateral sclerosis. Curr Opin Neurol. 2014;27:524–31.
   PubMed Web of Science ®Google Scholar
• Chen D, Guo X, Zheng Z, Wei Q, Song W, Cao B, et al. Depression and anxiety in ALS: correlations between the distress of patients and caregivers. Muscle Nerve. 2014.
   Web of Science ®Google Scholar
• Pagnini F, Lunetta C, Rossi G, Banfi P, Gorni K, Cellotto N, et al. Existential well-being and spirituality of individuals with amyotrophic lateral sclerosis is related to psychological well-being of their caregivers. Amyotroph Lateral Scler. 2011;12:105–8.
   PubMed Web of Science ®Google Scholar
• Canadian Agency for Drugs and Technologies in Health. Available at: http://www.cadth.ca/en/resources/finding-evidence-is/greymatters.
   Google Scholar
• Egger M, Juni P, Bartlett C, Holenstein F, Sterne J. How important are comprehensive literature searches and the assessment of trial quality in systematic reviews? Empirical study. Health Technol Assess. 2003;7:1–76.
   PubMedGoogle Scholar